VIDAvision for lung volume analysis in emphysema

The technology described is VIDAvision. It is used for lung volume analysis in people with advanced emphysema who are being considered for lung reduction procedures.

The innovative aspects are that it uses fissure integrity values to assess people with severe emphysema for endobronchial lung volume reduction surgery.

The intended place in therapy would be in addition to current lung function and standard CT scans or as an alternative to bronchoscopy in people with severe emphysema.

The main points from the evidence summarised in this briefing are from 3 studies done in Germany, Brazil and an international multicentre study including 323 adults in hospital settings. VIDAvision may have a role in selecting patients for lung volume reduction surgery but prospective comparative studies are needed.

Key uncertainties around the evidence or technology are that it is based on 3 small populations and the evidence was generated using an unvalidated prediction model for patient selection.

The cost of VIDAvision is £286 to £446 per scan (excluding VAT). The resource impact may be less than standard care only if its use improves patient selection for lung volume reduction surgery and other invasive treatments.